For Patients
Earlier answers, earlier intervention.
Outcomes · Patient
What LiverTwin™ means for patients
For the millions living with undiagnosed advanced liver fibrosis, earlier identification means the chance to intervene before cirrhosis, before liver failure, before transplant. LiverTwin transforms a silent, invisible disease into something visible — giving patients a diagnosis, a care plan, and access to emerging therapies like resmetirom while intervention is still possible.
Early detection
Found before F4
Identifying fibrosis at F2–F3 preserves treatment options — the window where lifestyle change and pharmacotherapy can reverse damage.
Continuity
Monitored over time
Longitudinal tracking means fibrosis progression — or regression — is caught early, keeping the care team ahead of the disease curve.